Profile
James Zabrecky worked as a Biochemistry Director at AutoImmune, Inc., a Principal at Oncogene Science, Inc. and Agenus, Inc., Head-Process Development & Manufacturing at Provenance Biopharmaceuticals Corp., and Vice President-Biologics Development at BioVest Health Sciences, Inc. He holds a doctorate degree from the University of California, Berkeley.
Former positions of James Zabrecky
| Companies | Position | End |
|---|---|---|
Oncogene Science, Inc.
Oncogene Science, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostics services | Corporate Officer/Principal | - |
AutoImmune, Inc.
AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Corporate Officer/Principal | - |
BioVest Health Sciences, Inc. | Corporate Officer/Principal | - |
| AGENUS INC. | Corporate Officer/Principal | - |
Provenance Biopharmaceuticals Corp.
Provenance Biopharmaceuticals Corp. BiotechnologyHealth Technology Develops novel therapeutics for cancer | Corporate Officer/Principal | - |
Training of James Zabrecky
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Oncogene Science, Inc.
Oncogene Science, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostics services | Health Services |
AutoImmune, Inc.
AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Health Technology |
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Provenance Biopharmaceuticals Corp.
Provenance Biopharmaceuticals Corp. BiotechnologyHealth Technology Develops novel therapeutics for cancer | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioVest Health Sciences, Inc. |
- Stock Market
- Insiders
- James Zabrecky
















